Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyohei Nakamura

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2021
[The immune microenvironment of multiple myeloma]Kyohei Nakamura
Immunotargets and Therapy|July 23, 2021
The Cancer-Immunity Cycle in Multiple MyelomaMika Casey, Kyohei Nakamura
Immunology and Cell Biology|December 22, 2016
Targeting cancer-related inflammation in the era of immunotherapyKyohei Nakamura, Mark J Smyth
Cellular & Molecular Immunology|October 16, 2019
Myeloid immunosuppression and immune checkpoints in the tumor microenvironmentKyohei Nakamura, Mark J Smyth
Immunity|June 20, 2020
Natural Killers out of Thin AirKyohei Nakamura, Mark J Smyth
Modern Rheumatology|June 16, 2010
Generalized laxity of connective tissue as a possible syndrome in systemic lupus erythematosusKyohei Nakamura, Yumi Tajima, Osamu Takai
Journal of Hematology & Oncology|August 14, 2020
Targeting immune checkpoints in hematological malignanciesBasit Salik, Mark J Smyth, Kyohei Nakamura
Blood|July 10, 2020
Cancer immunoediting and immune dysregulation in multiple myelomaKyohei Nakamura, Mark J Smyth, Ludovic Martinet
Immunology and Cell Biology|June 15, 2020
Cancer-killing, decoy-resistant interleukin-18Kyohei Nakamura, Tobias Bald, Mark J Smyth
Blood Advances|July 13, 2022
Invariant NKT cells dictate antitumor immunity elicited by a bispecific antibody cotargeting CD3 and BCMAMika Casey, Cui Tu, Simon J Harrison, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2021
[The immune microenvironment of multiple myeloma]Kyohei Nakamura
Immunotargets and Therapy|July 23, 2021
The Cancer-Immunity Cycle in Multiple MyelomaMika Casey, Kyohei Nakamura
Immunology and Cell Biology|December 22, 2016
Targeting cancer-related inflammation in the era of immunotherapyKyohei Nakamura, Mark J Smyth
Cellular & Molecular Immunology|October 16, 2019
Myeloid immunosuppression and immune checkpoints in the tumor microenvironmentKyohei Nakamura, Mark J Smyth
Immunity|June 20, 2020
Natural Killers out of Thin AirKyohei Nakamura, Mark J Smyth
Modern Rheumatology|June 16, 2010
Generalized laxity of connective tissue as a possible syndrome in systemic lupus erythematosusKyohei Nakamura, Yumi Tajima, Osamu Takai
Journal of Hematology & Oncology|August 14, 2020
Targeting immune checkpoints in hematological malignanciesBasit Salik, Mark J Smyth, Kyohei Nakamura
Blood|July 10, 2020
Cancer immunoediting and immune dysregulation in multiple myelomaKyohei Nakamura, Mark J Smyth, Ludovic Martinet
Immunology and Cell Biology|June 15, 2020
Cancer-killing, decoy-resistant interleukin-18Kyohei Nakamura, Tobias Bald, Mark J Smyth
Blood Advances|July 13, 2022
Invariant NKT cells dictate antitumor immunity elicited by a bispecific antibody cotargeting CD3 and BCMAMika Casey, Cui Tu, Simon J Harrison, et al.
Pageof 5